A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma

BACKGROUND AND AIMS: Nonalcoholic steatohepatitis (NASH) is a common inflammatory liver condition that may lead to cirrhosis and hepatocellular carcinoma (HCC). Risk factors for NASH include a saturated fat diet, altered lipid metabolism, and genetic and epigenetic factors, including microRNAs. Seru...

Descripción completa

Detalles Bibliográficos
Autores principales: Tucker, Robin D., Ciofoaia, Victor, Nadella, Sandeep, Gay, Martha D., Cao, Hong, Huber, Matthew, Safronenka, Anita, Shivapurkar, Narayan, Kallakury, Bhaskar, Kruger, Annie J., Kroemer, Alexander H. K., Smith, Jill P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946881/
https://www.ncbi.nlm.nih.gov/pubmed/31297627
http://dx.doi.org/10.1007/s10620-019-05722-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946881/
https://www.ncbi.nlm.nih.gov/pubmed/31297627
http://dx.doi.org/10.1007/s10620-019-05722-3

Ejemplares similares